FDA PLAYER NGSXE .015 WILL BE 0.50 WHEN/IF DRUG APPROVED:
knulp
Thursday, May 16, 2013 11:01:37 AM
Re: ash111 post# 3009360
Post # of 3009457
FDA PLAYER NGSXE .015 WILL BE 0.50 WHEN/IF DRUG APPROVED,REMEMBER DRUG WAS ALREADY APPROVED,PH3 FOR FURTHER INDICATION LED BY ACORDA, IN CASE OF APPROVAL A LOT OF MONEY TO NGSXE AND COMMONS, COMPANY ISN'T IN BANKRUPTCY BUT SOLD MOST OF ITS ASSETS TO ACORDA FOR MONEY,POTENTIAL ROYALTIES, BATGAIN ATHESE PPS IMO
NGSXE .015$ 33M OS 10M FLOAT NOBRAINER,FDA PLAYER, ONGOGOING PH3 PLUS FDA APPROVED DRUGS,SOLD TO ACORDA BUT MAY BE ENTITLED TO BIG ROYALTIES IF APPROVAL COMES IN NEXT YEARS,MARKET CAP 400K $ WAS MULTI DOLLAR PLAYER,AT 0.05 MARKET CAP COULD BE LESS THAN 2MLN$ FOR A MULTI MILLION $ DRUG AND ROYALTIES,NO BANKRUPTCY HERE, REGULATORY NEWS MAY COME AT ANY MOMENT
alert NGSXE PPS MAY STABILIZE AROUND .05 OR 1.6MLN$ MC, ACORDA THERAPEUTICS WILL RELEASE KEY DATA AND REGULATORY DECISIONS IN NEXT WEEKS/MONTHS/YEARS,EVERY PH3 ADVANCEMENT WILL PUSH PPS IMHO,ONE OF THE BIGGEST MARKET MISS, TILL .05 VERY LOW RESISTANCE
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
